These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21664627)

  • 1. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
    Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
    Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
    Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
    Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
    Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
    Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
    Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
    Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
    Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
    Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
    J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.
    Flores-Ramírez R; Uribe-Longoria A; Rangel-Fuentes MM; Gutiérrez-Fajardo P; Salazar-Riojas R; Cervantes-García D; Treviño-Ortiz JH; Benavides-Chereti GJ; Espinosa-Oliveros LP; Limón-Rodríguez RH; Monreal-Puente R; González-Treviño JL; Rojas-Martínez A
    Cardiovasc Revasc Med; 2010; 11(2):72-8. PubMed ID: 20347795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience].
    Yerebakan C; Uğurlucan M; Kaminski A; Westphal B; Liebold A; Steinhoff G
    Anadolu Kardiyol Derg; 2009 Dec; 9(6):457-64. PubMed ID: 19965315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial.
    Colombo A; Castellani M; Piccaluga E; Pusineri E; Palatresi S; Longari V; Canzi C; Sacchi E; Rossi E; Rech R; Gerundini P; Viecca M; Deliliers GL; Rebulla P; Soligo D; Giordano R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):239-48. PubMed ID: 21372740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
    Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
    Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
    Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction.
    Laguna G; DI Stefano S; Maroto L; Fulquet E; Echevarría JR; Revilla A; Urueña N; Sevilla T; Arnold R; Ramos B; Gutiérrez H; Serrador A; San Román JA
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):259-267. PubMed ID: 29582623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
    Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
    Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.
    Agbulut O; Vandervelde S; Al Attar N; Larghero J; Ghostine S; Léobon B; Robidel E; Borsani P; Le Lorc'h M; Bissery A; Chomienne C; Bruneval P; Marolleau JP; Vilquin JT; Hagège A; Samuel JL; Menasché P
    J Am Coll Cardiol; 2004 Jul; 44(2):458-63. PubMed ID: 15261948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision making and results of coronary artery bypass grafting for patients with poor left ventricular function.
    Uyar IS; Sahin V; Akpinar MB; Abacilar F; Yurtman V; Okur FF; Ates M; Tavli T
    Heart Surg Forum; 2013 Jun; 16(3):E118-24. PubMed ID: 23803233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.
    Donndorf P; Kundt G; Kaminski A; Yerebakan C; Liebold A; Steinhoff G; Glass A
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):911-20. PubMed ID: 21376346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.
    Yoo KJ; Kim HO; Kwak YL; Kang SM; Jang YS; Lim SH; Hwang KC; Cho SW; Yang YS; Li RK; Kim BS
    Can J Surg; 2008 Aug; 51(4):269-75. PubMed ID: 18815649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of autologous bone marrow-derived cells into the myocardium of patients undergoing coronary bypass.
    Oakley RE; Al msherqi Z; Lim SK; Lee SH; Ho KT; Sutandar A; Lee CN; Lim YT
    Heart Surg Forum; 2005; 8(5):E348-50. PubMed ID: 16099737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
    Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
    Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.